Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M3 | ||
Ligand | BDBM50522814 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1888526 (CHEMBL4390203) | ||
Ki | 0.880000±n/a nM | ||
Citation | Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M3 | |||
Name: | Muscarinic acetylcholine receptor M3 | ||
Synonyms: | ACM3_HUMAN | CHRM3 | Cholinergic, muscarinic M3 | Muscarinic Receptors M3 | Muscarinic receptor M3 | RecName: Full=Muscarinic acetylcholine receptor M3 | ||
Type: | Enzyme | ||
Mol. Mass.: | 66151.03 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P20309 | ||
Residue: | 590 | ||
Sequence: |
| ||
BDBM50522814 | |||
n/a | |||
Name | BDBM50522814 | ||
Synonyms: | CHEMBL4461243 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H34BrNO4 | ||
Mol. Mass. | 552.499 | ||
SMILES | [Br-].OC(C(=O)OC1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1ccccc1)c1ccccc1 |(13.28,-19.41,;3.37,-21.2,;4.71,-21.98,;6.04,-22.74,;6.05,-24.28,;7.38,-21.97,;8.71,-22.74,;10.04,-21.96,;11.36,-22.74,;12.7,-21.97,;14.03,-22.74,;15.37,-21.97,;16.7,-22.75,;18.03,-21.98,;19.36,-22.76,;20.69,-21.99,;20.7,-20.45,;19.36,-19.68,;18.03,-20.45,;11.37,-24.28,;10.04,-25.04,;8.71,-24.28,;10.2,-24.07,;9.85,-23.02,;4.7,-20.44,;6.03,-19.67,;6.03,-18.13,;4.69,-17.36,;3.36,-18.14,;3.37,-19.68,;3.38,-22.75,;2.04,-21.98,;.71,-22.75,;.72,-24.29,;2.06,-25.06,;3.39,-24.28,)| | ||
Structure |